Viewing Opinion | StockChase
Johnson & Johnson (JNJ-N) opinion on 2017-09-12

Last Price Recorded: 138.0000 on 2017-11-17

ON STOCKCHASE SINCE Oct 2000

biotechnology/pharmaceutical
PAST TOP PICK

Christine Poole
Johnson & Johnson was $132.630 at time of opinion
Owned : Yes

(A Top Pick Sept 13/16. Up 16%.) Still likes this. Their pharmaceutical division, consumer products division and medical device division all play into an aging demographics. The pharmaceutical division is doing quite well right now. Has a lot of new products that are doing well. She sees decent earnings growth in the high single digits range. Very strong balance sheet. Pays a dividend of just over 2%, and has increased the dividend for the last 56 years.

BULLISH

All opinions for JNJ-N (380)

116 BUY
17 BUY on WEAKNESS
50 COMMENT
44 DON'T BUY
27 HOLD
3 PARTIAL BUY
5 PARTIAL SELL
35 PAST TOP PICK
3 SELL
1 STRONG BUY
61 TOP PICK
3 VAGUE
6 WAIT
5 WATCH
4 WEAK BUY
View All

More experts covering JNJ-N

SAVE
Add JNJ-N to Watch List

All opinions for JNJ-N (380)

116 BUY
17 BUY on WEAKNESS
50 COMMENT
44 DON'T BUY
27 HOLD
3 PARTIAL BUY
5 PARTIAL SELL
35 PAST TOP PICK
3 SELL
1 STRONG BUY
61 TOP PICK
3 VAGUE
6 WAIT
5 WATCH
4 WEAK BUY
View All

More experts covering JNJ-N

SAVE
Add JNJ-N to Watch List

No Comments.


You must be logged in to comment.

Successfully Saved Company